Valérie Combaret

Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis

Emmanuel Barillot, Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, 2013, PloS one.

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Olivier Delattre, 2008, Nature.

ArrayCGH‐based classification of neuroblastoma into genomic subgroups

Frank Speleman, Björn Menten, Rogier Versteeg, 2007, Genes, chromosomes & cancer.

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.

Ruth Ladenstein, Gudrun Schleiermacher, Gian Paolo Tonini, 2009, The Lancet. Oncology.

Accumulation of segmental alterations determines progression in neuroblastoma.

Gudrun Schleiermacher, Jérôme Couturier, Isabelle Janoueix-Lerosey, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overall genomic pattern is a predictor of outcome in neuroblastoma.

Gudrun Schleiermacher, Frank Speleman, Jérôme Couturier, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.

Michael Baudis, Holger Christiansen, Frank Speleman, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma

Gudrun Schleiermacher, Olivier Delattre, David Gentien, 2016, Clinical Cancer Research.

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Gudrun Schleiermacher, Jan Koster, Javed Khan, 2015, Nature Genetics.